0001193125-11-121281.txt : 20110502 0001193125-11-121281.hdr.sgml : 20110502 20110502151644 ACCESSION NUMBER: 0001193125-11-121281 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20110502 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110502 DATE AS OF CHANGE: 20110502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 11800145 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2701 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 2, 2011

 

 

TENET HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   1-7293   95-2557091

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1445 Ross Avenue, Suite 1400, Dallas, Texas   75202
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (469) 893-2200

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events

On May 2, 2011, Tenet Healthcare Corporation issued a press release, which is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

  (d) The following exhibit is filed as a part of this Report.

 

Exhibit No.

 

Description

99.1   Press release issued on May 2, 2011.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TENET HEALTHCARE CORPORATION,
Date: May 2, 2011  
  By:  

/s/ Gary Ruff

    Name:   Gary Ruff
    Title:   Senior Vice President, General
      Counsel and Secretary


EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1   Press release issued on May 2, 2011.
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

TENET HEALTHCARE BOARD OF DIRECTORS TO REVIEW REVISED

UNSOLICITED PROPOSAL FROM COMMUNITY HEALTH SYSTEMS

Shareholders Advised to Take No Action at This Time

DALLAS – May 2, 2011 – Tenet Healthcare Corporation (NYSE: THC) today confirmed that it has received a revised proposal from Community Health Systems, Inc. (NYSE: CYH) to acquire all of the outstanding shares of Tenet for $7.25 per share in cash.

Consistent with its fiduciary duties and in consultation with its independent financial and legal advisors, Tenet’s Board of Directors will review the revised proposal to determine the course of action that it believes is in the best interests of the Company and its shareholders. Tenet’s shareholders are advised to take no action at this time pending the review of the revised proposal by the Tenet Board of Directors.

The Company noted that on November 12, 2010, Tenet received a proposal from Community Health to acquire Tenet for $6.00 per share in cash and stock. On April 18, 2011, Tenet received a proposal from Community Health to acquire Tenet for $6.00 per share in cash. In each instance, the Tenet Board of Directors, after consultation with its financial and legal advisors, unanimously determined that the Community Health proposals grossly undervalued Tenet and failed to reflect Tenet’s prospects for continued growth and shareholder value creation and were not in the best interests of Tenet or its shareholders.

Barclays Capital is acting as financial advisor to Tenet and Gibson, Dunn & Crutcher LLP and Debevoise & Plimpton LLP are acting as Tenet’s legal counsel.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers and diagnostic imaging centers. Tenet’s hospitals and related healthcare facilities are committed to providing high quality care to patients in the communities they serve. For more information, please visit www.tenethealth.com.

ADDITIONAL INFORMATION

Tenet Healthcare Corporation (“Tenet”) will file with the Securities and Exchange Commission (“SEC”) a proxy statement in connection with its 2011 annual meeting of stockholders. Any definitive proxy statement will be mailed to stockholders of Tenet. INVESTORS AND SECURITYHOLDERS OF TENET ARE URGED TO READ THESE AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and securityholders will be able to obtain free copies of these documents (when available) and other documents filed with the SEC by Tenet through the website maintained by the SEC at http://www.sec.gov.

CERTAIN INFORMATION REGARDING PARTICIPANTS

Tenet and certain of its respective directors and executive officers are deemed to be participants under the rules of the SEC. Information regarding these participants is contained in a filing under Rule 14a-12 filed by Tenet with the SEC on January 7, 2011. This filing and other documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants in any proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will also be included in any proxy statement and other relevant materials to be filed with the SEC if and when they become available.


Forward Looking Statements

Some of the statements in this release may constitute forward-looking statements. Such forward-looking statements are based on our current expectations and could be affected by numerous factors and are subject to various risks and uncertainties discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended Dec. 31, 2009, our quarterly reports on Form 10-Q, and periodic reports on Form 8-K. Do not rely on any forward-looking statement, as we cannot predict or control many of the factors that ultimately may affect our ability to achieve the results estimated. We make no promise to update any forward-looking statement, whether as a result of changes in underlying factors, new information, future events or otherwise.

Tenet uses its company web site to provide important information to investors about the company

including the posting of important announcements regarding financial performance and corporate developments.

Tenet Healthcare Corporation

 

Media:    Investors:
Rick Black (469) 893-2647    Thomas Rice (469) 893-2522
Rick.Black@tenethealth.com    Thomas.Rice@tenethealth.com
Joele Frank / Andrew Siegel   
Joele Frank, Wilkinson Brimmer Katcher   
(212) 355-4449   

# # #

 

- 2 -

GRAPHIC 3 g180999logo1.jpg GRAPHIC begin 644 g180999logo1.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`60"H`P$1``(1`0,1`?_$`-H```(!!`,!`0`````` M```````)"@(&!P@!!`4+`P$``04!`0$```````````````,$!08'`@$($``` M!@(!`P(!!080"`\!```!`@,$!08'"``1$@D3"B$Q0105%E&1(C)T%V&!L2,S ML[0U-E9VE[!JRTS34M;8W=W&AP=%BZ\\*DC,XQZ`3CPA?&W7E4T$T:37:[';(T6IVU--4R.,X)PYO>4W M)TB`<$OS?4EO/66.*MW`!%GJ#5L(_`5`Y8[%M/Z^*QC$:,+1:< MF9-G#=1Z)`5O6E,?`LM_T2HF`?FY8Z;H/;$MRKK@ZEQ(F4CPT$=IU$X<,R88 M)WK5/-A;5,%`G+'#Y=T=BN^X`]P/DXY'N.-'82=CW!/50^RVF.R$^R,DIU,D M9&1/<5DER"4.@&!3H/Z8<67TUZ3T@+=;*UYD?E3R0BBO9:Q2A"@!A[5)A(/A^/\_(MWI1M^M3*Q;@I M'7C^"H)!GVJU?[IPX0\3NBX(5)^B=#8$U'D.S.?RRC<+!_NL/&)DF>:U?*/Y M\M:YI=5-NX<95QVC*UQ@LB^ M\[2ZRF<@5@`$\I@GO[H?QA+8 M[`FR=63NV`,Q8WS)4U")'-.8XN4!;&C4RP")$)(L._=.(EWT`>J+HB*Q1`0$ MHIWA.86@C+R?R186*FGJDZJ=Q"QV&,T`(#\0XT2I*TA:? M9,+1SSJ"#A!!P@@X00<((.$$'""#A!!P@@X01J/N?O#K=H+AR1S?LM?VM,JK M=8T=7XAJD$K<[_8Q;*N6U1H%715(^L=A=D2$>PHIMVZ?59RLB@4ZI9BQV"Z[ MCKTVVT,J=JE0CYZ?D,]R5O/MW9+ M16L!VN:U'UZ?(.86+J5!=,4\M6*&6`R*LA>LJMFXS,7)221C=65>4CVS1,XI M"NZ,`KF^H=K])-O61I#EV0BNNZ3,SF6P?Q0WD9\)G=>]MN;,833/Z7*U29IIVY#3RU2 M(ER]8B&]ML-POBP^XH^%Q4K$R[SF8FRZB>UH\=6#Z]&.=AHZT[>9(!)%:7E[ MS-S=*QPWD"&[C)5K&E(F8\I(TAOP>DQ(S"BH!U,)0$2!\]WGJUNFXNK;MJTT M-)/!#:1J`XS61,DXDY2X1?[?M6ST:0O0EQ[BHY$]V6'\O&'PX;U/UBUWC$(C M!.OF&L1,6Y$R$+CW'%2JSE3TR]I%'4A$Q3:0>K@'RJ+*J*#\X\H%;=;I<5%= M?4/NJ.>I:CZ8G6:2EIQI9;0D=@$;``'3[OZ?(\``2$_.8<1SP*0><$4]H=1' MJ/Q^7XC^I\G.`TA*BH`ZCF9G'YX\(F<291KEF73W5/8=B\C\Z:XX3RRB^2,B MX7O>,ZA89+M.42B9"8?Q*LLS6`!^"B*Z9RC\0$!Y,4%[O5J4%6VKJ6)<$.*2 M/*`T"%:6OV\^A$+.(Y"U+<9TT)S''"9:)RCJMF>[UQ\ M54HE42:SE9MTI;JS/07JEZJ,10025#J`B`"(H2&`!CIH72D*4N_VBG)Q4!( MC/&4RMQ]88"')5&T15VJ\#;H(9(8>QQ;.8C?KB#FJS+%:/DBK(IR==L; M"+GX.03*;M6:/&R#E!0!(H0I@$`JKB"VLH5@H'G/YQG$HE:'$A;?L&+BYQ'4 M'""#A!!P@@X00<((.$$'""#A!$`GR;>)?SN>2[9NQ9RR)B/%T/38L7-:PIBU M/8ZBNX#%^/45P%LR9E%9))U9K&HB5]-R`I@H[=G!,.C=!NFG]'[-WWTQV=96 M[?2/N+KEB;[I;5ZRAD$X3T@93EW8DQ0;W9+[>*KQ%:13I]D$XCOQE&.='_:I M[=V38"K*;U%H^-M=*Z*5EMK+'>1XFZ77(ZL;(,5&^-H[ZJ;IDJ\;84A4"0EC MF,HW:$.1N45U2*)N]Q=;;.+8XG:R5+NZL$N*3I"1+$GC,<)"$+7LQ;-1XUQ* M2CD,\/F^>)B6V^]6DWB%P_A>.RU'2>*L2S;]QC'%-7Q-C5].PT+]F8,9?ZH; MP-7;D3AHYO&)B8AQ(!5%.O41.(B.&6/;NX][5]3^S4JJJ])"W"I0!.K\*:CC MB<<8N=9745G827O58.66&6&8Y]IS)XF%\?WIWQ'?Q_S=_,'>O\WY:/\`)WJ! M_G?$=_'_-W\P=Z_P`WX?Y.]0/[E_U&_P!*#^+K M+^.?F^N-_M!_+=IOY*+#DJL:MV"_3DKB>%KD_<2W#'<_2&[>/M3Z7CH47AN9Y2=%-`S,X_:'/E,,829%>"4#\I1`\F8 MPF!'=;=J"WR%2X$KE.7$=_RQX0M2E^Z8\2ELLK:ORE\S5CYFY<`W+;+QA"TH MU=$3"`$6=N*NI:99FW-U_'59E*4/B;H'+55]'=_4;/CJHPM$B?4<0HX=@.<1 MR=TV52@GQ1B1\_EA\.(,SXHS_0*]E7">0JEE+&]K:B\KUUI$XQL%>E$TSBDX M21?QZRR:3UDN4R3ALIV.&RQ3)JD(94%-G(@QI/OGY8=-?&W,XU@=J+9P-@(57M,H!A$O4"CRQ;E2QA&+,<^=+QI9'UUR#M0CGA2EX:QO>$<;3$SD6FVFHSL MU>W5?9V9K5Z13GD:K:;S,+Q#\B@(Q;1R<(-7^U.TRJM+J?"23WX9;R?2VK MIV#1*XW3"5^C:<0QC]A'#R0CHZ6D(YD?J`BLX:))IE^)Q*'7I,U?27?E'2_& M.T1+.DJP6@F0_P!6<_)*&S>Z;*X0D.R),L?],/KI%XJ&2:E7+[C^RP=SI%PA MF%BJMMK$JRFZ]88.40*YCY6'EH]9=F_8O&YP.FHF82F`?N]0YG3C3K*U,OI* M'DJ(*3@01S$3R'$.@+;]9H@$*&1G'F9*RGC?#5+G\CY9O53QMC^JLSR%CNEW MGXNLUJ&:D'IZC^7EW31F@90X@5,@F[U3B!"`8P@`J4M+55U0FDH6UO5:R`$( M$U&?&0X9GN!CIU;3*/$>4E*.TRA$-]]T-XCZ587$#&Y1RMD9)JN=NI8L?84N MCZMJ'3/V"=I(6-O6%I!N8?B11!%5,Y1`2B("'-%IND._:EL.HHI`C)3B`?-J MBNN[KLK2RV7)D<1*7TB&(:7^5'1/?TJS'67.]?MER9-5'TIB^?:R-&RE&,41 M#Z1(*42W-8F;D8IL`@*CQBF[:$Z@`J@/PY4[_M:_[9>\&\4RV\9:L"G_`-0P M^6$2E'=;?7@?"N)4HC*>([Q],IQY?D"\J>I?C.1Q8OM%*W^,2S$O;V]+-1J' M*7CUE:0G`*SP201:A!C03)96OI"?]E$3=/Q1XYVSLW<.[_&-B8#J6-.LE24R MUZI2U$3]DP5]THK8$FL5IUSEY)3^D0MW^]5^)/\`C9GW^86U?X_EJ_R9Z@_W M-/\`2M_I1&?Q59/^;\O/!_>J_$G_`!LS[_,+:O\`'\/\F>H/]S3_`$K?Z4'\ M563_`)OR\\,Y\?\`Y.-6O)?6\E6O5Z3O4E$8HL4'5[<>\4B2I+A*5L,4O,QI M8]O)*J*/VYV+\[5J6Z2]M>$^ZDJ2)@X#M&'FG$Q1UM M/7M^+3&:(81ROP[BGL#]'[X\\EVF/)=I\\<=@?+\?OC^IP`EE[7/C'0)`EPA M5/E3\4>,_*Q0L2T#)N5L@XIC\27:9O$6_P`>L*P^>R[Z:KJM=6921;1&R3=- MH@W4]0@I%*<3_*/3EPV7O2JV36/55.PU4+?;"5!R8&!!!$I8X2B)N]I8NS"6 M7C().!E/TCEQG$*7S>>#C"_BLP;AO*N-,XY8RG+9,R^MC>0BL@1E*8QL;&I4 MBQVKZR8J5B(C79I#Z7"II=JAC)BDH8>@&`!'Z(Z<]0JO>MSJJ2LI6&&FJ;6G M1,XA0!SQQ&&9QC/=PV"ELU*E]E6MQ2I2*0.7?SC%'@K\06'O*Z\V8:Y8RSE' M&`8/0Q2M`CC5M4%QF?M\:^$DOK@]KA)OM!C]DT?0!`J?7UCB<1Z%#CCJ/OJJ MV2JA31TS#ZJIMU2M8(`"5@)D4RQD2")PAMBS4UZ8<-00EQ"L"`,N4LHDFS.E M6*O;4:8[O[@X"RODO+V2*D MKNM(/6ZPJ%7;Q_IE`HF,;F0IO5SZM[HH+36LMLTK4U%*"=(0GUERG,B8!$^9 MPBXBA9VK;7ZIA16I66`$CESQEG$.SQ\Z49V\PF[3K'4GE&3^T%D:3V8=@<\7 M@[ZWST54VDQ'-9^?!LLY25L%LFYJ>;L8IDHLW:@JMW&,FW0,'-VW=N:U]/-M M)=:93X(]1EI,DIU`3Q''#/,]YBA6NVN[AN"OB"5?A*49F0RPB41M)[1'#;3" MY\RVOGJOPZLC"U_-[^FRU!R,^8H&67KRKNJTZMR=(D9GL$K-Z!WS5NL M8I5T3)F,JGC-DZZ7`7-#=ZI6%4*\"6P$%$S[0D*8FC4 MKQTI)Q$PHYRE+R0B3P%^1+(^A&\]*Q-9)";)@+8K($+A;,6.WKE8S*J7Z=G2 MU2G9(CHHZQF<99:G<':3*642`#.H=9P13U%$6XDTKJAMBEW)MI5TI&TB[,L? M$(<`D5,H$W$$_ADI`(G,@C`XF(+;-X=M]V%K?*O"7A(^R#Z(;#[R'H.3=!AZ M]?\`X-L.`C^B%@Q&`_>'E1Z!*"*>Z**0H_S9RQ_#P^N)3?H!=IPL`@!1RQ^7 M9"1_$_X;-@?*])W%U3\@5K$6"\2V&+A[WD2TMI2QN4[+88P'XPV/J)'KL$)Z MR!"M4%7RSE]&MT&ZC<#JJF,5(-`WIU!L^Q74,!D5%V>3JTI`;TC,%3@Q4)DR M!G*1E$19=MO71D*\1**0&8$@<3P^647/YB/"Y>O$W(8CFE6:#K M]K2J"]$L""GT9Y.4ZB<5&H"04S+*@;2^E>V*?;FV$5C[2%W.K`=<6H#4VT M1/0"K+#$@2$SRE%#75AI:>9;:5*60/9,8XSX0Z[3KVDV*+A@&H7?;G83 M*T7F&^56*LQZCA4U.BJAC?Z]8(R3"#?2-NJMDD[I-QK=P0K]8H1[3Z1WIHD, M0I5U,NO76RK:N:D6NEI!0H6I)\29*I',2(E\^<^R)VBV2PJE0JK40^<2`GNP M^7\L1QO)1H1F?PU[I5*IUW*+^74:,X3->N>=:^T-6+`XCXZ?/$8 MNUU2?B?0D6Z:JK-V@HDIT])R*!-?V?N:T=1MOJ55TZ"D39<0"5)"B)329DA. M([C/E%5NE'4;9O#:Z4R;P4D@`8XYSP.1PQRB8JIK#AKW.6BVENQN3\I9`PA; M\2IY+K-_@<7QU2>-/SN+FJM=R&V53M,7*BUA%7=0;RD21(0.#"4("HF,`"&# M4MYK>DE\K[,FF9J?%6E0*U+D$C44E)!$YZL>$QA%X>H:/=M$Q5.J*0E)&7$R M)XCD(C'^<[P[XC\3R&LQ\7YAR=E=7.CG+"$V3(D=4&"<$GCM&@K1ZD0:K1<8 M98\D-N6!8%P.!01)VB'4W-CZ<[V=WJFN-92M,&G+)3H)(DO4%`SX83!)/'E% M+W'MZBLP;\`ZU+YC+MBZ_!;X7<+>5RD;'6G+&8,L8O=X6NM"K$(VQLA3%FLP MTMM=F9IXYEAM=>FU@X#"("#7J/OFLV5<&*>BIJ=YI]"E> MOJF-)&4B)@SXS[(=6+;-ONS"G'"4E,LA.)O$WBEJ&8:=BG*&2< MGL\R6VMVV8>9'0JJ#J(=UB#[] MX5N\ZMJLK6TM*804)2"2)=D^'*-"L]H:LS!8945)//O/:><-;Y4HEH.$$'"" M#A!$0GWA7]3W5#^U*\_H?O/-SZ%_ORL_P7]8(HN_?N=/[RO1&KGLV/WX\@/Y M!K?^W9FY+]>O8M/N/_GIAET_^R?][TPQ'W;#R5;^,FDMF151C9#;;$Z$X=,Q MBE*U0IF4'S%-8`_!,FI*MD.@&^'J%+\_3E6Z'I0=Y/+)`6*!.?\^@9&D:@RC+AU)Y%/L6])$#K%`G>/XO/HC=%'M:LIFD;J^'^&2X2CQ7/#&J6,C,3 M,N'EC/;4[=VEJ-I"RN7K:1PF/3*&F!MM[H@.GQ\C/4/G'6!T/WP_,WT'E-%@ MZ.K'K+M:0?\`Y`F/]O.)8U.]]4P'=,+5CKC_\`I:7_``#?YRXD-D?NU?O_`%Q;GO%OZM^EW]H& M_?T7O.2/07][W'_"H_.A/?GW)GWO2F-._9RB(9SWK$H=Q@Q+A,2EZ@'<8+?? MQ*'4?@'4>2G7L3IK9/`>(]C_`$4,-BS"JDISTCTQ$.R.[E)'*&2'\N*QIU]D MZ^/9,5P[W`S3JZ3#A\"Q3%ZG<#(J'`0$OQ-\H?-S>&D-(M[:"I"F13MS),DR M\-,YDY#MBF5B5+KEIQU%>$L^$I0_]ONE[GE)LV39F\@?T--N@FT]#4P3(_1B M)%*AZ1BX3,!T_2*':;J/4/CU'F9?P[T>0I0UVTN3QU5"<#Q`DN+"*O>BC[-0 M#+D,N![XTUVDH?FKW7G:E9]J-?\`=W,T]0XB3@:A)6+6&YQBL'$3+UO(R;%L M2L8V@D%4WCUHFH8RQ5#@)``!`/ARPV:KZ?[<96Q8ZNVT[3BM2@E])*E2EQ4< M(8UM-N2N(U/Q3L!A33[8V@9YQ+E3#[@FRRMEJ-?RK1++ M0Y!_&S>,*&UE)2&86:,C'3V,4DX82&63*=/UR'+U[@$.8!UCK;37;E:/EC0KWE/[%X]/T'NS77]# MJUPKT^_TY;>@WV5X]QG^LB'WW_[?R_1&0O9M_P"R+?3_`'M86_U%M/&'7C]Z MVW_!>E,.=B_NU?O#TQ-$Y@T7>#A!!P@@X00<((B$^\*_J>ZH_P!J5Y_0]>>; MIT*2HWRM(!(%%_6"*-OQ*C1,*`,@H^B-7/9L?OQY`?R#6_\`;LSXJ M8G^25:CW1;[Y0_M*V.L2.M(U)EF2!PYSF1*/G+>*#R'W#Q.;F/,JS^/YNPUQ M["S^%-@L4+'^S=U;PH3\:]??0499(J4=?:#98!-9-F]!$B_1=HHJAZWK)_5. M^=FG?>VF_A%@5(5XC!S2J8D3/(I(R5B)R,9A9+FY8JU2GVU%LIDH8@@3S`P/ M#E$_N&]Q3X>Y>C(WE;;V'A#*,2.UZ5.4'*+3(3-P=/N&*6JB%,=NEY!-0.P1 M;G7;B;XE5$OX7/EYWI7OMNK^#7;G"].6H%/A]AUST@+0U#GYU0(SZQ?2*3PCEV@JHU01*H/)ZY=&[_:-N/7VK4CXAB2E--S4`G*> MI.!/&6(PSAG3;HI:JX(I60?AU8!9.9D?-]7FA:WO(?\`:9H,'4!'["[#_'K_ M`/8,1A]_EY_\?`LT]S6<1-H$C*N(/\24IX&@1^@]! M_--A+H/W!^V%_P"@_I#R5Z^#52VQ!G(N/'S>$89[$!"Z@G.2?3"0;+3%FS=I8DV(G+'GO#%B39+MX\C.\3KZ5N5(0<&*+0\SCNXNW"0I$4%0(U MPQ7.4GK=`O\`TTW'3;KVLTD'Q*ZG0&7FU2D0D:=?/24R))P!G,X3B!W);_V= M=U.`?V58U`8X'OSX2SB6UXYOP7BW;GM]2PD52BV\!(G&1[,I<=-4C&#-XJ0P(J6C)5OA&J@-43]#&3AXZ56/\`B_K? M7N#S;G1G=UX>2JM8%%23Q6N6H#W>??+RQ[6[LM%(#X2U.+3RF0>^?U2[8=/H M;N?BO?W5[&.SN)'7;"WJ(!*QUEP\;NYC'U^B3?0KICZP_1^WTY>KS)3I=QB) M@Z:F1=)E])<@C0;_`&*NVU>W[+<4%-2R9:B):@9Z3*0PECY9<(L-)5HK:9%0 MC!*A.(F/O)_\J\?(_'_^E@^4>GQ#"_7X?)\W-TZ#_=KN.)#,O]N*-OO`TYX8 M_1&3?9M_[(M]/][6%O\`46T\CNO((NMNG_6:8=;&PMRP<]0],30^H#\@A M\/T0Y@FI/,81=I@Y1SU#[O#6CF//'L'.H(.$$'""%*^7+Q5PWE>Q)BW$\[FR M9P>VQADY7)3>=@Z3'7EQ,K+5&;JAH=Q'R4_74F2)230K@L550W5/M[.@]0NF MR-Y/;*KGZUJF:J2\SX=`S48RSV/ZS&5^UQ^_O] M+TO0+T[NX>B^]]]U&]#2!VE9ID4R'!ZBE$J*U`XSR`D82LEBIK(VM#*E*4M4 MYGEW3.,.V$.H"'W0$/O\H9G+"4XG!@82YY&/!%HYY'9E7(MX@I_#V=Q8BQ-F MK#BT5!SU@(0XJ-0R'79&,D:O?S-3&$I'3MN25*ET2*\*F4I"WG:O4/.>7GY0ZG0KV]WCWT3F8C(+.F2FPF:H94CN*RKG@T7 M9E:T_3$PIO:11F4H&Z&1>@S9YN;J3NG="E(JGO!HU9MM M30DSX&1Q'9EV18[?MNUV_%M)4L9%6,NZ.?+WX3:YY9;)@JPS>Q%@P9^8^#O\ M*T:0F.HN^%L9;X_JC]9RY6D[5731IXTU6*4A2`L"H+"(B7M`!ZV%OU[8?Q'P MU(S4BH4E1"U*`!3,@R&>))CF];?8O2VU/+4GPP92Y^<1FGQ'>+&&\4>'F\K!T:.O*T\K.5E:MGC7#22L5=(P3;$5]8% M"G4$Q@[1*`?'BVRM[5>RZJHJ*=EM]+[:4%*S(2!GR.?9(QW=[4S=V4LO&24\ M?-EYHQ)XA?"%7/$U>,W76#V.L61X&(IF8/9U8DEK$^D<"[HY!H-:=.E%6E4RAC& M!RTAG#(ZHE`.]0P]1'9:#KI=&F`UJ%&96M14H]DSC(<(N+33;+8::`2@9`0I[R_\`AF@/+4M@-6=V"G\&?F*_ M./\`1BPF/8J^!9OSA!3@5^D_6=FK@Q?U5]D0[>SU?6]<>O;V!W7?8^_ZS9+5 M6RQ3M5#=46YZB1((F98`YD\)2B"O>WJ:]Z?'6I)2,///F(N'Q"^(V`\2-1SK M5X7/$WG-/-EII]J=/IVAQ5!-6S4^%E( MHCQEOG>[V\:MFJ72ML.-I*0ELE6K41,DJE*4H"V6J6/UWEYFP&-M;<'>.R@6#(>2IPD>T*.?+46 M+KL$T[75GNMF>)8K4"+JU1AP4=O5S!^*4J28&652(?S<72*W;)B3D.V.+=NRNN=0FGIZ88G%4\$]I[(FD\Q"+K!P@@X00<((.$$ M'""#A!!P@@X01;ENBIFWM.02B/.DK#:@XI'B)29E$Y:I?@SPE/*?#./""00# M(GCR[83C=-[=U]$I4\5O%JM;MB,#LW)T&&[>DU6=VLK6$*8@(R^>M6#O'U^Q MI)M$SE^GO:^^GX10W<=N5/J"!+A3V"S[A:#E@K44]<HUZ:MLJ8.2T`GOU#)(RQ)&,Y3C;O7GR@^/O:2*0D<+;=X/M#I5 MRDR4K4G=HRDWIH_6`1"/D*#>#5RXLWI3`)!3.R#\,!`!'D+<=M;BM:S^TJ-] ME(5*83K1_2)!00<\#E#I%PH7@E3;B!K$P"0%>8F?S1ODFJDJDFNDJFJBJ0BB M2R9RG2434*!DU$U"B)#D.40$!`1`0'D,2!G#H8Y17U`?D$!_3X3$I\((YYYJ M3S$$<=0#Y1#[_/9B4^$$C%)E"%(8YCD*0@&,V?ES\>VE\%*R69MF,4Q%U=YMU M%,.N(*AF`05#AD.W.;%'H,YRPD:'!VG5*?&$.X"DXZC MW_ZZE&I+++.E@*N]7<*E3]+Y)WCO:Y[UK"_6`-T"2?#:3.21V\2>T^26,]8M M-GIK0SH9Q>(]8\SV?+ER$FX\J$2L'""#A!!P@@X00<((.$$'""#A!!P@BDQ> M[I\1#I]P1#_C`0X8<^#EQ/9QUVK3'(:Q5`+EK%QCXQR6 M*JJ@JFI?KMG)E+\A0`.H#<-O[]W9MHA%!5%=&/^$\`XWW: M59)/$)EWQ&55HH:Q)#J`DGBCU3\V!\HA-[KVYVZ&NL@Z=>/CS";"8BKB9EC0 M6.\C*6QW#,40,;Z+'/)"G6U"KOVJ*(@7N&J%Z"'7L'Y.7I/5+;MS2H;KL%+4 M.*$M;(T*3C,E(`!$^6J(,[=N5,J=MJU!'$*GPRD1/RX18DYBCW=.`_695#.V M"]H(1D0QD'R(8*=R;M,@`4H*I9)H&*IXRIP+U[061[H3+>\:::4*;<2#F93(EY?H[9QKI:-W/=NU0YVT?ATY)4^W.A]0G4FO<01^.K3 MYIYP@Y7;P;E-E*I\A/Z$F,)V#;7W;^1`/&M<1;"TP'?ZWW5;53$-/]$##V"* M4S:*Z]5:CT/^.9P`ATZ@(=.2E/8NAU$?%54LO!(QFZLD_D@@3[H9N5>]7U:$ MME"589'#RZ1&!+5XSO&KEHWA7*D\X4 MI';]9[(S1AOV?NV]A19.LU[/X$Q$FX434=Q%"K=RRU--B',!EBJN7H8TA3N@ M`1Z=BZQ!-\ING&=9UTV\R@-VFWO.I"9>L0AM6'``*.GS0JUL:M=`76/)U'VC MB3\O+#Y]/?:^>.36US'V;+D;:]P+XQ61=)/,T+-&..&;I`Q3D488EJY6=??) M=X"/IS:\V3ITZ=!`1',K[U:W7>6U4K!9HZ)7!H$+[BLS/E&F+10[6M-$0L)* MW1Q.1\D2)J]7("I0L76JM"1%;KD&R;1D)7X"-9PT'#1K-,$6D=$Q,0R\T>US MV/8.$$'""#A!"\_(1Y)\#^-2L8:ONQ,==?L'F#,<5AX;54HUA+,Z$XD8&7L3 MBYV]BYDF$D>IP\="+&=#')/GP`'4C<_QZ3NW]LW'<[K[-KD:BG9+I23+6E,I MA.&)QRPG$?77&GMP07]7\XL)&&$S%]63>+%U?VQUOU*;Q%BLEHV@Q#D_-./+ M_7%Z_(8W3J&+F\([?GD)7ZZ3DW"MA9SR"T:HR:.FZR7X1U$P$HBS1:JE=HJ+ MR2D,4SH0I.(7-4^$L@1(\C*%S5MA]#"9$+3J!GWF0YX"-I4;[2%Y=S7DK?65 M+"S346>5\D]%GG6:"1$UE5G<05T,BU2106(`0LK#82HK(F!(XC*?GCK6C*8SEGQE.7FQ[L8N2.E(R89M9")D&4I' MOFR3QB_CG2#UD]9KAW(NFCML=1NY;*E^)3D,8I@^0><\9<1'0Q&H90L#-_DZ M'&.VMPTUQIISM%LYE:B8DI.:+4MA4<(-H&(IE]EYB"AEEG64+:`X%@J4`"0"EM>0Q)F)3$1;] MS#50JE0R\XXGBD89),\Q^,/+/E&7=,_(#BO<@5?O*W/6FF3<%8X-DLZ9OXZ5=('22,(B4.T3-KYMZNV]X M"ZE2':"J:\1AY!*D.IGI)29`^JJ:2"`008<4M8S5S*=2'4^TA6!&)$R/(8SW MD[8G&F.,'YESRWFF-_J>$<;WO)5I9X_F(*P2CF.H-1DKG)0\>9.33C"3C^+C M#`V3SMJ2W55+J&TE?JI!<4$@DRP$S,]F,H5> MJ6F:=RI)!;;25*D<@!,QY6%]F\7YEU\PEL=]9H8\I>=L<4W)5289'EZ_7YAI M&7:NL[,PB9(X2[F(/-,F#TH.$VSEPF4Q3"4YB]##[<;<]07-^U/R55TS[C2M M,R-;:BA0!&L5N/^M[%8(.OQ7JHH!)S7:E1\(A9I"VUEC6W(-#-;"\GHMK!.2OQ`K$6\NNZ3CUP>F,`)=J@^H/X MO7GI;U*\,IFH"L5EVRAT5DQ*<"F$2F#H/0>' MJAPH(DX`)@CGE'*5!0F@@CL,>OVAUZ]/B'/2`3./>V.>>P0<((.$$'""#A!! MP@A`7G.Q35\XV[Q08GO].&\XWOOD@IE/R+756+QY'O:;92E8<6R)S4VYJ*Y2&@X3.<1],U6TUP%"L3;:"RVK# M'4%2\WF$Y8`":K=2\3R;+(>L5EDLENJOY)X3=B-6ROCR!T=V(F-U;1R4]V[4F7J[9K&IPJJB1&PK%6(M8]PU:DTE4$TH7MIR MC(IG5OM"E`2V-"VF@WK#VK'1XA)_4F.6DNY:)M#G4,JU>IE+U6,4%F*W;]7;:1ZH^&55[F::I*@'2GX8L M@M^*%8Z=:I$G##U9RQA%U%>IU33.H4E)JTD3&KU@)*\FE0,B#(GNV+F=?,2S MFCFFF5=PKBEX]I:L1\+ M$,J;0MF,^U''UIIKO)B^*>3:I#&>RN=-4E(OQYZZ.C7O#=9Q;-J6]8 MN3KVB2LRYLO8ZO\``*M(]98CD$V(,W8G^!E@3$0Y*"Y45'TZI$UM.Q5__:/E M*%*6E2064@D%"T'/$3F)@3$(N-//79P-N*:/A2G($9M8X\\O)V&%1W/%6?,? M^/\`\XN&8^1RQE3=:N;D8J1W*SDUCK4\NNR^I;U[79&'O-4I$4O%BPBD,2O9 M:/EH*!=D1&.;.TR.$TETRIVREKKDZ<8]2*A%!4ME1%:%XJ'%)4J1X8%1),S@DB9BR]1,<4VJ.?($YU M4RI`Y`P_;?$?LTVS%3=:M+\ZZWZ\1]OC:!((8E/D!3-65;2Z>;)"5V^13;1$ M<[=+LCNOI2J9Q6,JK;O3(0MZK:?4&_&252+;+4FYXA9F! MP!$B6JP7FJA5*XMQE=$L$:2GUM!PXF(7&G/%0F9"=.@":E M',QR]ZX8\=2T4X82D'0HR.D82"A.9!'?G*8CV+1)M7^'_%K@;9A&GRD)4L6; M$7+%FQOEHAL\8WUI+C8,GV&#J%'D]>L?W>?/=?'MA'$VQ6=T\(U"F>3?;V4P%8 M?'/-P4'0\:.83'V9:E;+15+ACG']A<6YU(T`)-90\'%D$)7E).:IB1.4^4^(,_5GH/+DYXA<$4>GQ7T;3>A^5O*D#GJ[8KIN MPN5=?,B8630KLW1!1>MFRSQDD>DMZ%L7O3&X5RDYR/J_+Q^+K`U1QCK/DK7;4"&R^ M^/(IS88`8Y:R3;+0O*G@DC)V!NTCF\<*B30\_P`J+_X9OU`XFY]D[^K])AE5^TS^N_W8 MI=_B_P#GC_[;BCOVK?NJ^A4/1]YI_<5]!BI3][5?R-#]J+R+IOP^]KZ$Q[3^ MTGN$"_[`W_X/^VESVM_=Y]Y'_<3'*ONSW?Z8P_F?^!$_^7PG[K3Y+TO[[I_= M/IAI4?=D^X?H7%_T+^#5:_DK`?N!'B(^T7[Y^F'3'W5'=%T#^S+?]-;M]W?_`%I]$"/O`]R,C!^-^E_S<51[7Y(^DPX.45\6CR#A (!!P@@X01_]D_ ` end